2020 Israel Prize Awarded to Dr. Gideon Rechavi, ICRF International Scientific Council Member

As the struggle against COVID-19 continues, some good news from Israel: Gideon Rechavi, MD, PhD, a member of ICRF’s International Scientific Council (ISC) since 1999 and past ICRF grantee, has been selected to receive the 2020 Israel Prize for Medical Science.

Prof. Rechavi is the world-renowned head of the Sheba Cancer Research Center, which he founded and directs. He has dedicated his life to researching novel genetic and epigentic mechanisms affecting global gene expression and their implication in cancer.

“Prof. Gidi Rechavi is a uniquely talented physician investigator who has managed to achieve synergies between his clinical activities in the hospital and his work as a world class scientist,” said ICRF National Executive Director Mark A. Israel, MD. “His lab works on diverse fundamental problems in biology and disease, while being focused on the potential for clinical impact. Recognizing unmet needs in the clinic and bringing cutting-edge laboratory science to impact on these problems has been his mantra.”

We are truly grateful for his contributions to ICRF’s scientific excellence through our ISC, and commend him on this well-deserved honor.

ICRF is proud to have funded several past recipients of this esteemed award, including Prof. Yosef Yarden, Weizmann Institute of Science (2017), Dr. Yosef Shiloh, Tel Aviv University (2011) and Dr. Howard Cedar, Hebrew University (1999).

Read more in The Jerusalem Post.